(Q96773988)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

title

LOW SEROPREVALENCE OF LYME DISEASE AMONG MULTIPLE SCLEROSIS PATIENTS IN NEW BRUNSWICK (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

author name string

Gregg MacLean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

Peggy Cook

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

L Robbin Lindsay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

Todd F Hatchette

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

publication date

29 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

1 July 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada

1 July 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Lyme neuroborreliosis-epidemiology, diagnosis and management

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Imaging in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Borrelia burgdorferi antibodies in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Neuro-lyme disease: MR imaging findings

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Multiple sclerosis in Vest-Agder County, Norway

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2020.129

7 January 2021

Identifiers

DOI

10.1017/CJN.2020.129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32594964%20AND%20SRC:MED&resulttype=core&format=json

1 July 2020

1 reference